Cryo-Cell International, Inc. - Laporan Laba Rugi (TTM)

Cryo-Cell International, Inc.
US ˙ NYSEAM ˙ US2288951088

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Cryo-Cell International, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
11-30
2021
02-28
2021
05-31
2021
08-31
2021
11-30
2022
02-28
2022
05-31
2022
08-31
2022
11-30
2023
02-28
2023
05-31
2023
08-31
2023
11-30
2024
02-29
2024
05-31
2024
08-31
2024
11-30
2025
02-28
2025
05-31
Revenue 31 30 30 29 29 29 30 30 30 31 31 31 31 31 32 32 32 32 32
Change (%) -2.44 -2.19 -2.05 -0.77 1.38 1.46 0.60 1.50 1.87 0.45 0.61 0.36 0.09 0.86 0.62 0.46 0.36 -0.36
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 11 10 10 10 10 10 10 10 9 9 9 9 12 12 12 12 8 8 8
Change (%) -4.49 -2.47 0.97 -1.33 0.90 -0.21 -1.08 -13.07 -0.41 -0.67 -2.21 42.58 -0.01 -0.20 -0.25 -34.16 -1.03 -3.33
% of Revenue 35.13 34.39 34.30 35.35 35.15 34.99 34.41 33.84 28.98 28.34 28.02 27.23 38.69 38.65 38.25 37.92 24.85 24.50 23.77
Gross Operating Profit 20 20 20 19 19 19 19 20 22 22 22 23 19 19 20 20 24 24 24
Change (%) -1.33 -2.05 -3.63 -0.47 1.64 2.36 1.48 8.95 2.79 0.89 1.71 -15.44 0.15 1.53 1.16 21.61 0.83 0.61
% of Revenue 64.87 65.61 65.70 64.65 64.85 65.01 65.59 66.16 71.02 71.66 71.98 72.77 61.31 61.35 61.75 62.08 75.15 75.50 76.23
SG&A 14 14 13 14 15 15 15 15 16 16 16 16 17 18 18 18 19 19 19
Change (%) -3.06 -2.96 0.88 7.70 -0.39 5.25 0.72 1.00 3.23 0.79 1.24 4.61 3.20 -0.65 1.96 3.20 1.13 1.78
% of Revenue 45.89 45.60 45.25 46.60 50.58 49.70 51.55 51.61 51.36 52.04 52.22 52.55 54.77 56.47 55.63 56.37 57.90 58.35 59.60
R&D 0 0 0 0 0 0 0 0 0 0 1 1 1 2 2 1 1 1 1
Change (%) 1.96 -27.07 49.37 88.25 282.80 40.68 26.16 13.57 -17.77 70.73 48.85 45.69 36.20 -3.99 -9.80 -10.07 -32.57 -13.06
% of Revenue 0.08 0.08 0.06 0.09 0.17 0.65 0.90 1.13 1.27 1.02 1.74 2.57 3.74 5.09 4.84 4.34 3.88 2.61 2.28
OpEx 25 24 24 24 26 26 27 27 26 26 27 27 32 32 32 32 28 28 28
Change (%) -3.74 -1.84 1.88 4.79 1.68 3.19 0.31 -4.15 1.55 1.11 1.02 17.69 2.30 -1.31 0.24 -11.81 -0.42 0.33
% of Revenue 81.63 80.55 80.84 84.09 88.80 89.06 90.59 90.32 85.30 85.04 85.60 85.95 100.79 103.01 100.79 100.41 88.15 87.46 88.06
Operating Income 6 6 6 5 3 3 3 3 4 5 4 4 -0 -1 -0 -0 4 4 4
Change (%) 3.32 -3.66 -18.67 -30.15 -1.04 -12.65 3.40 54.21 3.69 -3.32 -1.85 -105.63 282.35 -73.58 -47.66 -3,003.44 6.19 -5.14
% of Revenue 18.37 19.45 19.16 15.91 11.20 10.94 9.41 9.68 14.70 14.96 14.40 14.05 -0.79 -3.01 -0.79 -0.41 11.85 12.54 11.94
Interest Expense -2 -1 -1 -1 -1 -1 -1 -1 -1 -1 -2 -2 -1 -1 -1 -1 -2 -2 -2
Change (%) -5.51 -1.64 -0.20 -3.72 1.88 -4.62 -2.49 -17.68 14.89 33.78 -6.99 -19.56 -13.30 -38.23 52.32 84.82 10.36 12.98
% of Revenue -4.96 -4.80 -4.83 -4.92 -4.77 -4.80 -4.51 -4.37 -3.55 -4.00 -5.33 -4.92 -3.95 -3.42 -2.09 -3.17 -5.83 -6.41 -7.27
Net Income 4 4 4 4 2 2 2 1 3 3 2 3 -10 -10 -9 -9 0 0 -0
Change (%) 0.18 5.98 1.87 -46.86 6.65 -24.12 -23.11 113.78 -2.35 -15.29 9.32 -479.93 2.21 -4.47 -3.99 -104.50 -67.99 -233.09
% of Revenue 11.64 11.95 12.95 13.47 7.21 7.59 5.67 4.34 9.14 8.76 7.38 8.02 -30.38 -31.02 -29.38 -28.04 1.26 0.40 -0.54

Source: Capital IQ

Other Listings
DE:ZCY € 3.66
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista